Latest News in the pharma Industry

Market News

Atriva Therapeutics received Notice of Allowance from USPTO

Atriva Therapeutics received Notice of Allowance from USPTO

6 Nov 2016

Patent will cover a method of treating a subject having a viral infection caused by an influenza virus with neuraminidase inhibitors in combination with MEK inhibitors.

Read more 
Breakthrough immunotherapy for blood cancer becomes available to UK patients

Breakthrough immunotherapy for blood cancer becomes available to UK patients

6 Nov 2016

First early access scheme for breakthrough immunotherapy in blood cancer.

Read more 
CMS establishes unique J-code for Bendeka Injection

CMS establishes unique J-code for Bendeka Injection

3 Nov 2016

Provides access for patients and streamlined reimbursement.

Read more 
Endo begins shipment of generic Seroquel XR

Endo begins shipment of generic Seroquel XR

3 Nov 2016

Four dosage strengths of quetiapine fumarate extended release tablets being distributed.

Read more 
Key success factors to consider when implementing a global serialisation strategy

Key success factors to consider when implementing a global serialisation strategy

3 Nov 2016

TraceLink to present on global serialisation strategies at Pharmaceutical Serialisation & Traceability 2016.

Read more 
Recipharm invests in its Italian API facility

Recipharm invests in its Italian API facility

2 Nov 2016

As well as increasing output, the company is also investing in new technologies, including flow chemistry, chromatography and hydrogenation capabilities.

Read more 
CPhI India launches India Pharma Week in celebration of its 10th anniversary

CPhI India launches India Pharma Week in celebration of its 10th anniversary

2 Nov 2016

10 events to drive India’s rapid pharma growth predicted to reach $55bn by 2020.

Read more 
AmpliPhi Biosciences granted Small and Medium Enterprise status by EMA

AmpliPhi Biosciences granted Small and Medium Enterprise status by EMA

1 Nov 2016

Europe to be a key market for the company's phage-based therapies to treat bacterial infections in patients with unmet medical needs.

Read more 
Seasonal influenza vaccines market will hit $4.3 billion by 2025

Seasonal influenza vaccines market will hit $4.3 billion by 2025

1 Nov 2016

Amendments to the national immunization schedules of the US and the UK, the expansion of egg-based quadrivalent seasonal influenza vaccines across Germany, Italy, France, and Spain, and the transition from egg-based to cell culture-based vaccines will ...

Read more 
Daiichi Sankyo to commercialize two products formulated with SentryBond abuse-deterrent technology

Daiichi Sankyo to commercialize two products formulated with SentryBond abuse-deterrent technology

1 Nov 2016

MorphaBond is an abuse-deterrent formulation of extended release morphine using physical and chemical barriers, without the use of aversive agents or opioid antagonists.

Read more 
Allergan successfully completes Tobira Therapeutics acquisition

Allergan successfully completes Tobira Therapeutics acquisition

1 Nov 2016

Acquisition adds global rights to highly differentiated compounds to treat multi-factorial elements of NASH.

Read more 
Novartis wins two prestigious Prix Galien Foundation Awards

Novartis wins two prestigious Prix Galien Foundation Awards

31 Oct 2016

Gleevec recognized as "Discovery of the Decade" for Best Pharmaceutical Product, Cosentyx as Best Biotechnology Product.

Read more